On November 27, 2009
GlaxoSmithKline Target of Claims That Denture Cream Causes Neurological Problems
Could denture cream become GlaxoSmithKline (GSK)’s new Paxil — a blockbuster product that becomes the target of mass litigation? Lawyers have brought at least a dozen cases and are potentially preparing as many as 3,000 against GSK and Procter & Gamble (PG) over the use of zinc in the denture creams Poligrip and Fixodent, respectively.
0 Comments